ESK-001 is under clinical development by Alumis and currently in Phase II for Systemic Lupus Erythematosus. According to GlobalData, Phase II drugs for Systemic Lupus Erythematosus have a 39% phase ...
More than 8000 Queensland households had the cooling function on their airconditioner turned off remotely by Energex on a sweltering Sunday earlier this month – the fifth Big Brother-style inter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback